参天製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/09 | 982 | 1,006 | 973 | 998 | -2 | -0.2% | 3,657,900 |
| 2022/11/08 | 999 | 1,001 | 990 | 1,000 | +8 | +0.8% | 845,500 |
| 2022/11/07 | 985 | 1,001 | 983 | 992 | +10 | +1% | 1,103,200 |
| 2022/11/04 | 994 | 999 | 979 | 982 | -24 | -2.4% | 1,288,500 |
| 2022/11/02 | 997 | 1,014 | 993 | 1,006 | +5 | +0.5% | 1,382,400 |
| 2022/11/01 | 1,014 | 1,018 | 1,001 | 1,001 | -17 | -1.7% | 1,307,400 |
| 2022/10/31 | 1,011 | 1,023 | 1,001 | 1,018 | +30 | +3% | 2,311,200 |
| 2022/10/28 | 981 | 1,000 | 978 | 988 | -3 | -0.3% | 1,458,400 |
| 2022/10/27 | 1,007 | 1,007 | 990 | 991 | -18 | -1.8% | 1,094,000 |
| 2022/10/26 | 986 | 1,012 | 984 | 1,009 | +33 | +3.4% | 1,781,600 |
| 2022/10/25 | 982 | 982 | 972 | 976 | +1 | +0.1% | 956,000 |
| 2022/10/24 | 977 | 982 | 972 | 975 | +13 | +1.4% | 1,088,100 |
| 2022/10/21 | 975 | 977 | 962 | 962 | -18 | -1.8% | 1,344,500 |
| 2022/10/20 | 978 | 987 | 976 | 980 | -13 | -1.3% | 1,299,700 |
| 2022/10/19 | 995 | 1,008 | 992 | 993 | -2 | -0.2% | 1,093,900 |
| 2022/10/18 | 993 | 999 | 988 | 995 | +12 | +1.2% | 1,080,100 |
| 2022/10/17 | 994 | 995 | 981 | 983 | -11 | -1.1% | 861,000 |
| 2022/10/14 | 992 | 1,000 | 984 | 994 | +11 | +1.1% | 1,024,100 |
| 2022/10/13 | 987 | 988 | 973 | 983 | ±0 | ±0% | 881,000 |
| 2022/10/12 | 987 | 990 | 976 | 983 | -1 | -0.1% | 1,013,000 |
| 2022/10/11 | 979 | 990 | 975 | 984 | -9 | -0.9% | 1,013,700 |
| 2022/10/07 | 980 | 996 | 979 | 993 | -1 | -0.1% | 1,130,800 |
| 2022/10/06 | 1,000 | 1,009 | 993 | 994 | -5 | -0.5% | 1,290,400 |
| 2022/10/05 | 1,002 | 1,003 | 991 | 999 | ±0 | ±0% | 1,400,500 |
| 2022/10/04 | 978 | 1,000 | 974 | 999 | +33 | +3.4% | 1,846,500 |
| 2022/10/03 | 967 | 972 | 956 | 966 | -9 | -0.9% | 1,671,300 |
| 2022/09/30 | 987 | 990 | 970 | 975 | -11 | -1.1% | 2,534,900 |
| 2022/09/29 | 969 | 990 | 957 | 986 | +16 | +1.6% | 2,274,200 |
| 2022/09/28 | 962 | 972 | 959 | 970 | ±0 | ±0% | 2,121,100 |
| 2022/09/27 | 965 | 978 | 963 | 970 | +4 | +0.4% | 1,885,200 |
| 2022/09/26 | 964 | 977 | 960 | 966 | +2 | +0.2% | 2,816,000 |
| 2022/09/22 | 968 | 970 | 960 | 964 | -18 | -1.8% | 1,979,600 |
| 2022/09/21 | 976 | 985 | 972 | 982 | +3 | +0.3% | 1,463,500 |
| 2022/09/20 | 982 | 985 | 978 | 979 | -3 | -0.3% | 1,559,000 |
| 2022/09/16 | 977 | 985 | 973 | 982 | -4 | -0.4% | 2,030,800 |
| 2022/09/15 | 980 | 990 | 976 | 986 | +1 | +0.1% | 1,648,600 |
| 2022/09/14 | 988 | 993 | 979 | 985 | -22 | -2.2% | 2,544,400 |
| 2022/09/13 | 1,017 | 1,024 | 1,001 | 1,007 | -16 | -1.6% | 1,537,600 |
| 2022/09/12 | 1,014 | 1,027 | 1,009 | 1,023 | +14 | +1.4% | 1,387,100 |
| 2022/09/09 | 1,005 | 1,017 | 1,002 | 1,009 | +8 | +0.8% | 2,144,300 |
| 2022/09/08 | 994 | 1,002 | 988 | 1,001 | +18 | +1.8% | 1,742,300 |
| 2022/09/07 | 989 | 989 | 978 | 983 | -2 | -0.2% | 1,383,200 |
| 2022/09/06 | 996 | 1,004 | 985 | 985 | -3 | -0.3% | 1,155,200 |
| 2022/09/05 | 985 | 993 | 984 | 988 | -7 | -0.7% | 972,300 |
| 2022/09/02 | 991 | 995 | 976 | 995 | +10 | +1% | 2,147,500 |
| 2022/09/01 | 989 | 998 | 985 | 985 | -21 | -2.1% | 2,036,900 |
| 2022/08/31 | 997 | 1,006 | 996 | 1,006 | +1 | +0.1% | 1,336,900 |
| 2022/08/30 | 1,003 | 1,005 | 996 | 1,005 | +3 | +0.3% | 1,162,100 |
| 2022/08/29 | 988 | 1,003 | 986 | 1,002 | -2 | -0.2% | 1,558,200 |
| 2022/08/26 | 1,011 | 1,012 | 999 | 1,004 | -6 | -0.6% | 1,322,700 |
651～
700
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 参天薬 | 167,300円 | -2.0% | -7.3% | 2.27% | 16.59倍 | 1.97倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| エーザイ | 413,000円 | +0.1% | -3.4% | 3.87% | 28.08倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 158,400円 | +0.6% | +43.3% | 5.05% | 11.11倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
| ロート | 206,800円 | +8.4% | +0.2% | 2.03% | 15.03倍 | 1.80倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 住友ファーマ | 89,500円 | -11.0% | +206.6% | 0.00% | 8.89倍 | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム
